NBIX
Neurocrine Biosciences·NASDAQ
--
--(--)
--
--(--)
NBIX fundamentals
Neurocrine Biosciences (NBIX) expects to report earnings on Feb 11, 2026, with estimated revenue of 790.99M (YoY +26.01%), and EPS at 1.809 (YoY +80.90%).
Revenue estimate / YoY
790.99M
+26.01%
EPS estimate / YoY
1.809
+80.90%
Report date
Feb 11, 2026
Earnings Call
4:30 PM on Feb 11, 2026
Meeting link.EPS
Revenue
Revenue & Expenses
NBIX has released its 2025 Q3 earnings report, with revenue of 794.90M, reflecting a YoY change of 27.78%, and net profit of 209.50M, showing a YoY change of 61.40%. The Sankey diagram below clearly presents NBIX's revenue sources and cost distribution.
Key Indicators
Neurocrine Biosciences (NBIX) key financial stats and ratios, covering profitability, financial health, and leverage.
Neurocrine Biosciences (NBIX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Neurocrine Biosciences (NBIX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Neurocrine Biosciences (NBIX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Neurocrine Biosciences (NBIX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Neurocrine Biosciences (NBIX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Neurocrine Biosciences’s earnings call?What is Neurocrine Biosciences's latest dividend and current dividend yield?What is Neurocrine Biosciences's gross profit margin?What guidance did Neurocrine Biosciences's management provide for the next earnings period?What does Neurocrine Biosciences do and what are its main business segments?Did Neurocrine Biosciences beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Neurocrine Biosciences year over year?What is the market's earnings forecast for Neurocrine Biosciences next quarter?
